One such compound, PRI-724, binds with high affinity to the N-terminus of CBP and influences the expression of β-catenin target genes associated with cancer cell survival (e.g., survivin, c-Myc, and cyclin D1) while leaving p300-mediated β-catenin activity unaffected [31]. The gene discussed is CREBBP; the disease is cancer.